Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences

Joo Hyun Oh, Dae Won Jun

Clin Mol Hepatol. 2024;30(2):168-170. Published online March 5, 2024

DOI: https://doi.org/10.3350/cmh.2024.0140

View: 1000 Download: 31 Crossref: 1

Original Article

Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide

Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi

Clin Mol Hepatol. 2024;30(1):49-63. Published online November 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0328

View: 2047 Download: 178 Crossref: 2

Review

Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management

Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra

Clin Mol Hepatol. 2023;29(Suppl):S286-S301. Published online December 28, 2022

DOI: https://doi.org/10.3350/cmh.2022.0392

View: 5085 Download: 244 Web of Science: 9 Crossref: 9

Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis

Yi-wen Shi, Jian-Gao Fan

Clin Mol Hepatol. 2023;29(Suppl):S228-S243. Published online December 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0401

View: 3319 Download: 103

Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease

Peter Konyn, Aijaz Ahmed, Donghee Kim

Clin Mol Hepatol. 2023;29(Suppl):S43-S57. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0351

View: 3560 Download: 152 Web of Science: 13 Crossref: 13

Correspondence

Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”

Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2023;29(4):1050-1051. Published online August 29, 2023

DOI: https://doi.org/10.3350/cmh.2023.0310

View: 1306 Download: 34

Special Review

Waiting for the changes after the adoption of steatotic liver disease

Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2023;29(4):844-850. Published online September 6, 2023

DOI: https://doi.org/10.3350/cmh.2023.0291

View: 1972 Download: 160 Web of Science: 4 Crossref: 11

Editorial

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?

Heejoon Jang, Won Kim

Clin Mol Hepatol. 2023;29(2):381-383. Published online March 9, 2023

DOI: https://doi.org/10.3350/cmh.2023.0088

View: 2514 Download: 75 Web of Science: 2 Crossref: 2

Letter to the Editor

Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”

Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim

Clin Mol Hepatol. 2023;29(1):173-175. Published online November 15, 2022

DOI: https://doi.org/10.3350/cmh.2022.0372

View: 2577 Download: 41 Web of Science: 1 Crossref: 1

Editorial

Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey

Susana G Rodrigues

Clin Mol Hepatol. 2023;29(1):110-112. Published online December 12, 2022

DOI: https://doi.org/10.3350/cmh.2022.0414

View: 3178 Download: 95 Web of Science: 1 Crossref: 2

Snapshot

Personalized medicine in nonalcoholic fatty liver disease

Carlos J. Pirola, Silvia Sookoian

Clin Mol Hepatol. 2022;28(4):935-938. Published online June 24, 2022

DOI: https://doi.org/10.3350/cmh.2022.0175

View: 3533 Download: 135 Web of Science: 4 Crossref: 4

Original Article

Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide population-based study in hepatitis B virus-endemic area

Bo Hyun Kim, Dahhay Lee, Kyu-Won Jung, Young-Joo Won, Hyunsoon Cho

Clin Mol Hepatol. 2022;28(2):242-253. Published online February 7, 2022

DOI: https://doi.org/10.3350/cmh.2021.0355

View: 5042 Download: 121 Web of Science: 13 Crossref: 12

Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods

Seung Mi Lee, Suhyun Hwangbo, Errol R. Norwitz, Ja Nam Koo, Ig Hwan Oh, Eun Saem Choi, Young Mi Jung, Sun Min Kim, Byoung Jae Kim, Sang Youn Kim, Gyoung Min Kim, Won Kim, Sae Kyung Joo, Sue Shin, Chan-Wook Park, Taesung Park, Joong Shin Park

Clin Mol Hepatol. 2022;28(1):105-116. Published online October 15, 2021

DOI: https://doi.org/10.3350/cmh.2021.0174

View: 6517 Download: 197 Web of Science: 6 Crossref: 7

Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry

Jong Man Kim, Deok Gie Kim, Jihyun Kim, Keunsung Lee, Kwang-Woong Lee, Je Ho Ryu, Bong-Wan Kim, Dong Lak Choi, Young Kyoung You, Dong-Sik Kim, Yang Won Nah, Koo Jeong Kang, Jai Young Cho, Geun Hong, Hee Chul Yu, Ju Ik Moon, Dongho Choi, Shin Hwang, Myoung Soo Kim

Clin Mol Hepatol. 2021;27(3):451-462. Published online February 2, 2021

DOI: https://doi.org/10.3350/cmh.2020.0292

View: 6869 Download: 309 Web of Science: 31 Crossref: 33

Association between new-onset liver cirrhosis and suicide risk in South Korea: A nationwide cohort study

Suk-Yong Jang, Woo Sun Rou, Seok Hyun Kim, Byung Seok Lee, Hyuk Soo Eun

Clin Mol Hepatol. 2021;27(2):283-294. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0227

View: 5499 Download: 186 Web of Science: 7 Crossref: 9

Obesity and the risk of primary liver cancer: A systematic review and meta-analysis

Won Sohn, Hyun Woong Lee, Sangheun Lee, Jin Hong Lim, Min Woo Lee, Chan Hyuk Park, Seung Kew Yoon

Clin Mol Hepatol. 2021;27(1):157-174. Published online November 26, 2020

DOI: https://doi.org/10.3350/cmh.2020.0176

View: 9081 Download: 389 Web of Science: 67 Crossref: 73

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Alcohol and hepatocarcinogenesis

Makiko Taniai

Clin Mol Hepatol. 2020;26(4):736-741. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0203

View: 6084 Download: 175 Web of Science: 23 Crossref: 21

Original Article

Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B

Haneulsaem Shin, Yeon Woo Jung, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Yeun-Yoon Kim, Jin-Young Choi, Seung Up Kim

Clin Mol Hepatol. 2019;25(4):390-399. Published online May 31, 2019

DOI: https://doi.org/10.3350/cmh.2018.0103

View: 6076 Download: 145 Web of Science: 19 Crossref: 19

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B

Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik

Clin Mol Hepatol. 2017;23(2):170-178. Published online May 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0086

View: 9370 Download: 218 Web of Science: 50 Crossref: 44

Review

Factors affecting drug-induced liver injury: antithyroid drugs as instances

Reza Heidari, Hossein Niknahad, Akram Jamshidzadeh, Narges Abdoli

Clin Mol Hepatol. 2014;20(3):237-248. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.237

View: 17022 Download: 327 Web of Science: 37 Crossref: 42

Risk stratification of HBV infection in Asia-Pacific region

Jia-Horng Kao

Clin Mol Hepatol. 2014;20(3):223-227. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.223

View: 8744 Download: 85 Web of Science: 19 Crossref: 17

Original Article

Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population: a cross-sectional study

Hai Jin Kim, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2014;20(2):154-161. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.154

View: 7192 Download: 72 Web of Science: 6 Crossref: 6

Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis

Pei Chuan Tsung, Soo Hyung Ryu, In Hye Cha, Hee Won Cho, Jin Nam Kim, You Sun Kim, Jeong Seop Moon

Clin Mol Hepatol. 2013;19(2):131-139. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.131

View: 8779 Download: 93 Crossref: 31

Current status of Liver diseases in Korea: Hepatocellular carcinoma

Il Han Song , Kyung Sik Kim

Clin Mol Hepatol. 2009;15(60):50-59. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.S6.S50

View: 6066 Download: 49 Crossref: 41

3

Risk factors for early recurrence after surgical resection for hepatocellular carcinoma

Ui Jun Park, M.D., Yong Hoon Kim, M.D., Koo Jeong Kang, M.D., Tae Jin Lim, M.D.

Clin Mol Hepatol. 2008;14(3):371-380. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.371

View: 5049 Download: 52 Crossref: 12

Natural history of gastric varices and risk factors for bleeding

Choong Hyeon Lee, M.D., Joon Hyoek Lee, M.D., Ph.D., Yong Sung Choi, M.D., Seung Woon Paik, M.D., Dong Hyun Sinn, M.D., Choon Young Lee, M.D., Kwang Cheol Koh, M.D., Geum-Youn Gwak, M.D., Moon Seok Choi, M.D., Byung Chul Yoo, M.D.

Clin Mol Hepatol. 2008;14(3):331-341. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.331

View: 4789 Download: 66 Crossref: 12

Nonalcoholic fatty Liver disease as a risk factor of cardiovascular disease; Relation of non-alcoholic fatty Liver disease to carotid atherosclerosis

Su-Yeon Choi, M.D., Donghee Kim, M.D., Jin Hwa Kang, M.D. Min Jung Park, M.D., Young Sun Kim, M.D., Seon Hee Lim, M.D., Chung Hyeon Kim, M.D., Hyo-Suk Lee, M.D.

Clin Mol Hepatol. 2008;14(1):77-88. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.77

View: 6455 Download: 129 Crossref: 30

7

The Korean Journal of Serum Hepatitis B Virus DHA Level and Hepatocellulor Carcinoma

Seong Gyu Hwang

Clin Mol Hepatol. 2006;12(4):583-586. Published online January 1, 1970

View: 2360 Download: 15

3

Risk Factors of Morbidity and Mortality Following Surgical Resection for Hepatocellular Carcinoma

Wan Wook Kim, M.D., Kwang-Woong Lee, M.D., Sung Ho Choi, M.D., Jin Seok Heo, M.D., Yong Il Kim, M.D., Sung Ju Kim, M.D., Dae Sung Lee, M.D., Hwan Hyo Lee, M.D., Seung Woon Paik, M.D. Kwang Cheol Koh, M.D. Joon Hyoek Lee, M.D. Moon Seok Choi, M.D. , Byung Chul Yoo, M.D. and Jae Won Joh, M.D.

Clin Mol Hepatol. 2004;10(1):51-61. Published online January 1, 1970

View: 2818 Download: 19

Establishment of Individual Prediction Model According to Risk Factorsfor Development of Hepatocellular Carcinoma in Korea : Establishment of Individual Prediction Model for Hepatocellular Carcinoma

Jae Youn Cheong, M.D., Kwang-Hyub Han, M.D., Dong Kee Kim, Ph.D.*, Sang Hoon Ahn, M.D., Ki Jun Song, M.S.*, Yong Han Paik, M.D., Chang Hwan Choi, M.D., Hyun Woong Lee, M.D., Young Soo Park, M.D., Chae Yoon Chon, M.D., and Young Myoung Moon, M.D.,

Clin Mol Hepatol. 2001;7(4):449-458. Published online January 1, 1970

View: 2191 Download: 18

1 |

Viewed By 5247	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5180	MAFLD: How is it different from NAFLD?
Viewed By 5100	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3817	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3750	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search